by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Clinical Trials, Drugs (Pharmaceuticals), Economics, Finance, Food and Drug Administration, Generic Brands and Products, Law and Legislation, Non-Bank Loans, United States Politics and Government, Working Capital
The Senate capped a difficult seven months on Thursday by approving financing for the F.D.A. and expanding access to experimental treatments for people with terminal illnesses.
